The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Selumetinib plus docetaxel as second-line chemotherapy in KRAS mutant, KRAS amplified or MEK signatured gastric cancer patients: First arm of the umbrella trial in GC though the molecular screening, VIKTORY trial.
 
Jeeyun Lee
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Iwanka Kozarewa
No Relationships to Disclose
 
Hee Kyung Kim
No Relationships to Disclose
 
Kyung Kim
No Relationships to Disclose
 
Peter G. Mortimer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Simon J. Hollingsworth
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - Royalties. (I)
 
Ju Lee
No Relationships to Disclose
 
Minhwa Park
No Relationships to Disclose
 
Se Hoon Park
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly
 
Kyoung Mee Kim
No Relationships to Disclose
 
Elizabeth Harrington
No Relationships to Disclose
 
Won Ki Kang
No Relationships to Disclose